The Valley Desk

NCT00301366 · Interventional trial

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

Overall registry status Completed

Phase 3

Conditions Alpha 1-Antitrypsin Deficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov